StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Geron's operating cash flow for the twelve months ending Jun 30, 2026 was -$114.38M. For fiscal 2025 it was -$111.04M. The highest annual figure on record is $9.35M in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$111.04M–
FY2024Dec 31, 2024-$218.62M–
FY2023Dec 31, 2023-$167.74M–
FY2022Dec 31, 2022-$127.38M–
FY2021Dec 31, 2021-$95.56M–
FY2020Dec 31, 2020-$66.65M–
FY2019Dec 31, 2019-$43.83M–
FY2018Dec 31, 2018-$21.01M–
FY2017Dec 31, 2017-$20.56M–
FY2016Dec 31, 2016-$18.37M–
FY2015Dec 31, 2015-$24.20M-358.8%
FY2014Dec 31, 2014$9.35M–
FY2013Dec 31, 2013-$36.68M–
FY2012Dec 31, 2012-$55.15M–
FY2011Dec 31, 2011-$62.39M–
FY2010Dec 31, 2010-$44.29M–
FY2009Dec 31, 2009-$43.37M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.83M–
Q1 FY2026Mar 31, 2026-$62.91M–
Q4 FY2025Dec 31, 2025-$22.07M–
Q3 FY2025Sep 30, 2025-$13.58M–
Q2 FY2025Jun 30, 2025-$27.42M–
Q1 FY2025Mar 31, 2025-$47.98M–
Q4 FY2024Dec 31, 2024-$43.95M–
Q3 FY2024Sep 30, 2024-$58.94M–
Q2 FY2024Jun 30, 2024-$53.48M–
Q1 FY2024Mar 31, 2024-$62.25M–
Q4 FY2023Dec 31, 2023-$40.94M–
Q3 FY2023Sep 30, 2023-$50.84M–
Q2 FY2023Jun 30, 2023-$29.60M–
Q1 FY2023Mar 31, 2023-$46.37M–
Q4 FY2022Dec 31, 2022-$35.18M–
Q3 FY2022Sep 30, 2022-$29.58M–
Q2 FY2022Jun 30, 2022-$28.64M–
Q1 FY2022Mar 31, 2022-$33.97M–
Q4 FY2021Dec 31, 2021-$22.17M–
Q3 FY2021Sep 30, 2021-$22.84M–
Q2 FY2021Jun 30, 2021-$17.81M–
Q1 FY2021Mar 31, 2021-$32.73M–
Q4 FY2020Dec 31, 2020-$12.61M–
Q3 FY2020Sep 30, 2020-$15.45M–
Q2 FY2020Jun 30, 2020-$12.40M–
Q1 FY2020Mar 31, 2020-$26.19M–
Q4 FY2019Dec 31, 2019-$10.37M–
Q3 FY2019Sep 30, 2019-$11.98M–
Q2 FY2019Jun 30, 2019-$8.75M–
Q1 FY2019Mar 31, 2019-$12.74M–
Q4 FY2018Dec 31, 2018-$3.01M–
Q3 FY2018Sep 30, 2018-$6.14M–
Q2 FY2018Jun 30, 2018-$4.50M–
Q1 FY2018Mar 31, 2018-$7.37M–
Q4 FY2017Dec 31, 2017-$4.39M–
Q3 FY2017Sep 30, 2017-$4.42M–
Q2 FY2017Jun 30, 2017-$4.44M–
Q1 FY2017Mar 31, 2017-$7.31M–
Q4 FY2016Dec 31, 2016-$602.00K–
Q3 FY2016Sep 30, 2016-$6.55M–

More Geron figures

See a number that looks wrong?